obesity – Page 2 – Dr. Barry Dworkin

Study discusses how BMI should not be the sole indicator of potential health risks when there are other scales like waist circumference that add context to the evaluation.

July 6, 2023

Medical Mythbusting Commentary for July 6, 2023 Source:Being overweight may not be associated with early death, study says Reference:Body mass index and all-cause mortality in a 21st century U.S. population: A National Health Interview Survey analysis
Global diabetes cases could soar to 1.3 billion by 2050, new study says.

June 26, 2023

Medical Mythbusting Commentary for June 26, 2023 Source:Global diabetes cases could soar to 1.3 billion by 2050, new study says Reference:Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021
Sunday House Call, #881, June 18, 2023: When Experts Talk Out of Orifices That were Not Designed for Speech.

June 18, 2023

A review of this article that makes specious claims and extrapolations following the fat-bias and societal-disdain playbook that are not experienced by those who are using semaglutide (Ozemoic, Wegovy) for weight loss management. Your calls about:
Obesity changes the brain, with ‘no sign of reversibility,’ expert says. Brain responses to nutrients are severely impaired and not reversed by weight loss in humans with obesity: a randomized crossover study

June 14, 2023

Medical Mythbusting Commentary for June 14, 2023 Source:Obesity changes the brain, with ‘no sign of reversibility,’ expert says Reference:Brain responses to nutrients are severely impaired and not reversed by weight loss in humans with obesity: a randomized crossover study
Sunday House Call, #869, March 12, 2023:The Shame of the Shame of It All: An interview with Dr. Yoni Freedhoff (@YoniFreedhoff) about the attitudes and moralizing directed towards people with obesity.

March 12, 2023

Your calls about:
Meta-analyses of randomized controlled trials looks at efficacy of semaglutide (Ozempic) in treating people suffering with obesity

December 19, 2022

Medical Mythbusting Commentary for December 19, 2022 Source:Efficacy of Semaglutide in Treating Obesity: A Systematic Review of Randomized Controlled Trials (RCTs)
Diabetes drug in short supply in U.S. (but not in Canada) after celebrities, influencers touted its weight-loss benefits.

December 15, 2022

Medical Mythbusting Commentary for December 15, 2022 Source:Diabetes drug in short supply in U.S. after celebrities, influencers touted its weight-loss benefits
Wegovy (semaglutide) approved by FDA to support people struggling to lose weight (and that includes many). Health Canada did so in November 2021. Major addition to weight-loss management options.

June 8, 2022

Medical Mythbusting Commentary for June 8, 2022 Source:Weight-loss drug called Wegovy receives FDA approval
Treatments for weight loss do exist, work well for many, and reveal our growing understanding of how our homeostatic, motivational, and executive brain centers interact with respect to weight control.

May 11, 2022

Medical Mythbusting Commentary for May 11, 2022 Source:People Taking New Hunger-Blocking Drug Lose 24 Kilograms On Average